Karon Abe

1.6k total citations
46 papers, 1.2k citations indexed

About

Karon Abe is a scholar working on Internal Medicine, Molecular Biology and Hematology. According to data from OpenAlex, Karon Abe has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Internal Medicine, 11 papers in Molecular Biology and 11 papers in Hematology. Recurrent topics in Karon Abe's work include Venous Thromboembolism Diagnosis and Management (16 papers), Protein Kinase Regulation and GTPase Signaling (8 papers) and Acute Myocardial Infarction Research (5 papers). Karon Abe is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (16 papers), Protein Kinase Regulation and GTPase Signaling (8 papers) and Acute Myocardial Infarction Research (5 papers). Karon Abe collaborates with scholars based in United States, Thailand and Poland. Karon Abe's co-authors include Channing J. Der, Sharon L. Campbell, Kent L. Rossman, Ian P. Whitehead, Betty Liu, Keith Burridge, Kimberly Ritola, Derek Y. Chiang, W. Craig Hooper and William M. Callaghan and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Karon Abe

45 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karon Abe United States 18 475 179 175 165 144 46 1.2k
M A Forbes United Kingdom 15 423 0.9× 78 0.4× 82 0.5× 72 0.4× 95 0.7× 29 1.1k
Hongbo Yang United States 24 326 0.7× 71 0.4× 42 0.2× 328 2.0× 112 0.8× 136 1.9k
Ronit Elhasid Israel 22 437 0.9× 59 0.3× 183 1.0× 9 0.1× 406 2.8× 113 1.8k
Shamkant Mulgaonkar United States 22 367 0.8× 38 0.2× 140 0.8× 16 0.1× 106 0.7× 38 2.0k
Zoltán Vajó Hungary 19 503 1.1× 49 0.3× 35 0.2× 17 0.1× 26 0.2× 60 1.4k
Mehdi Benchaïb France 21 479 1.0× 16 0.1× 324 1.9× 662 4.0× 64 0.4× 79 2.1k
Vajira H. W. Dissanayake Sri Lanka 16 384 0.8× 23 0.1× 226 1.3× 194 1.2× 90 0.6× 153 1.3k
Samuel H. Pepkowitz United States 20 197 0.4× 18 0.1× 200 1.1× 72 0.4× 224 1.6× 54 1.5k
Masaru Ido Japan 18 277 0.6× 42 0.2× 43 0.2× 10 0.1× 273 1.9× 80 1.1k
Pilar Medina Spain 25 368 0.8× 19 0.1× 15 0.1× 58 0.4× 439 3.0× 82 1.3k

Countries citing papers authored by Karon Abe

Since Specialization
Citations

This map shows the geographic impact of Karon Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karon Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karon Abe more than expected).

Fields of papers citing papers by Karon Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karon Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karon Abe. The network helps show where Karon Abe may publish in the future.

Co-authorship network of co-authors of Karon Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Karon Abe. A scholar is included among the top collaborators of Karon Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karon Abe. Karon Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braun, Barbara I., et al.. (2024). Venous thromboembolism performance measurement in the United States: An evolving landscape with many stakeholders. Journal of Hospital Medicine. 19(9). 827–840. 1 indexed citations
2.
Lam, Barbara D., Rachel Rosovsky, Laura E. Dodge, et al.. (2024). Artificial intelligence meets venous thromboembolism: informaticians’ insights on diagnosis, prevention, and management. PubMed. 1(4). 100031–100031.
3.
Lam, Barbara D., Thita Chiasakul, Dimitra Karagkouni, et al.. (2024). Machine learning natural language processing for identifying venous thromboembolism: systematic review and meta-analysis. Blood Advances. 8(12). 2991–3000. 11 indexed citations
4.
Kapoor, Sargam, Maragatha Kuchibhatla, Alys Adamski, et al.. (2024). An epidemiologic study comparing cancer- and noncancer-associated venous thromboembolism in a racially diverse Southeastern United States county. Research and Practice in Thrombosis and Haemostasis. 8(4). 102420–102420. 1 indexed citations
5.
Lam, Barbara D., W. Robertson, Rachel Rosovsky, et al.. (2023). Artificial intelligence for venous thromboembolism prophylaxis: Clinician perspectives. Research and Practice in Thrombosis and Haemostasis. 7(8). 102272–102272. 1 indexed citations
6.
Lam, Barbara D., Laura E. Dodge, S. K. Datta, et al.. (2023). HTRS2023.P4.12 Perceptions on the potential for artificial intelligence to improve venous thromboembolism prevention. Research and Practice in Thrombosis and Haemostasis. 7. 100260–100260. 1 indexed citations
7.
Adamski, Alys, Maragatha Kuchibhatla, Karon Abe, et al.. (2022). Racial differences in venous thromboembolism: A surveillance program in Durham County, North Carolina. Research and Practice in Thrombosis and Haemostasis. 6(5). e12769–e12769. 4 indexed citations
8.
Raskob, Gary E., Aaron M. Wendelboe, Janis E. Campbell, et al.. (2022). Cancer‐associated venous thromboembolism: Incidence and features in a racially diverse population. Journal of Thrombosis and Haemostasis. 20(10). 2366–2378. 8 indexed citations
9.
10.
Byams, Vanessa R., et al.. (2022). Bleeding Disorders in Women and Girls: State of the Science and CDC Collaborative Programs. Journal of Women s Health. 31(3). 301–309. 6 indexed citations
11.
Payne, Amanda B., Laura A. Schieve, Karon Abe, et al.. (2022). COVID-19 and Sickle Cell Disease–Related Deaths Reported in the United States. Public Health Reports. 137(2). 234–238. 12 indexed citations
12.
Abe, Karon, et al.. (2019). Higher rates of bleeding and use of treatment products among young boys compared to girls with von Willebrand disease. American Journal of Hematology. 95(1). 10–17. 15 indexed citations
13.
Abe, Karon, Elena V. Kuklina, W. Craig Hooper, & William M. Callaghan. (2019). Venous thromboembolism as a cause of severe maternal morbidity and mortality in the United States. Seminars in Perinatology. 43(4). 200–204. 66 indexed citations
14.
Abe, Karon, et al.. (2010). Late Preterm Birth and Risk of Developing Asthma. The Journal of Pediatrics. 157(1). 74–78. 43 indexed citations
15.
Palmby, Todd R., Karon Abe, Antoine E. Karnoub, & Channing J. Der. (2004). Vav Transformation Requires Activation of Multiple GTPases and Regulation of Gene Expression. Molecular Cancer Research. 2(12). 702–711. 20 indexed citations
16.
Abe, Karon, Margaret A. Honein, & Cynthia A. Moore. (2003). Maternal febrile illnesses, medication use, and the risk of congenital renal anomalies. Birth Defects Research Part A Clinical and Molecular Teratology. 67(11). 911–918. 36 indexed citations
17.
Abe, Karon, et al.. (2002). TNF alpha up-regulates the expression and function of amyloid beta receptor in murine microgial cells. The FASEB Journal. 16(5). 1 indexed citations
18.
Palmby, Todd R., Karon Abe, & Channing J. Der. (2002). Critical Role of the Pleckstrin Homology and Cysteine-rich Domains in Vav Signaling and Transforming Activity. Journal of Biological Chemistry. 277(42). 39350–39359. 23 indexed citations
19.
Abe, Karon, Kent L. Rossman, Betty Liu, et al.. (2000). Vav2 Is an Activator of Cdc42, Rac1, and RhoA. Journal of Biological Chemistry. 275(14). 10141–10149. 222 indexed citations
20.
Whitehead, Ian P., Karon Abe, Jerome L. Gorski, & Channing J. Der. (1998). CDC42 and FGD1 Cause Distinct Signaling and Transforming Activities. Molecular and Cellular Biology. 18(8). 4689–4697. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M A Forbes Breakdown of academic impact, for papers by Hongbo Yang Breakdown of academic impact, for papers by Ronit Elhasid Breakdown of academic impact, for papers by Shamkant Mulgaonkar Breakdown of academic impact, for papers by Zoltán Vajó Breakdown of academic impact, for papers by Mehdi Benchaïb Breakdown of academic impact, for papers by Vajira H. W. Dissanayake Breakdown of academic impact, for papers by Samuel H. Pepkowitz Breakdown of academic impact, for papers by Masaru Ido Breakdown of academic impact, for papers by Pilar Medina
Rankless by CCL
2026